A Hepatite C no NEF apresenta uma taxa de prevalência de 4,96%, dos quais 13,2% são cirróticos. Genótipo 1 e bilirrubina maior que 1,3 mg% na consulta inicial apresentaram associação positiva e a condição de doador de sangue e de atleta profissional apresentaram associa protetora ao diagnóstico de cirrose. A frequência de diabetes mellitus foi 8,78% e esteve associada à idade maior que 35 anos e à mortalidade. A taxa de carcinoma hepatocelular foi estimada em 5,45%. A mortalidade nos pacientes com hepatite C foi de 4,10%.
A taxa de abandono de acompanhamento foi de 67.5%
Os dados sinalizam que portadores de hepatite C, cirróticos e diabéticos suscitam atenção especial e nestas situações o screening para carcinoma hepatocelular talvez necessite de TC.
Verificou-se uma necessidade de se planejar estratégias para melhorar o acesso e diminuir a perda de acompanhamento desses pacientes.
REFERÊNCIAS
ADEBAJO, Corlan O. et al. Ultrasound‐based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: A
systematic review and meta‐analysis. Liver Transplantation, v. 18, n. 3, p. 323-331, 2012.
ALBERTI, A. et al. Review article: chronic hepatitis C–natural history and cofactors.
Alimentary pharmacology & therapeutics, v. 22, n. s2, p. 74-78, 2005.
ALTER, Miriam J. et al. The natural history of community-acquired hepatitis C in the United States. New England journal of medicine, v. 327, n. 27, p. 1899-1905, 1992.
ALTER, Miriam J. Prevention of spread of hepatitis C. Hepatology, v. 36, n. 5B, p. s93-s98, 2002.
ALVARIZ, Fernando Guerra. Hepatite C crônica: história natural. Revista Hospital
Universitário Pedro Ernesto, v. 5, n. 1, 2006.
ANDERSON, Frank H. et al. An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C. Hepatology Research, v. 18, n. 1, p. 63-71, 2000.
ANSALDI, Filippo et al. Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World journal of
gastroenterology: WJG, v. 20, n. 29, p. 9633, 2014.
ARENA, Umberto et al. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. Hepatology, v. 58, n. 1, p. 65-72, 2013.
BACKUS, Lisa I. et al. Predictors of response of US veterans to treatment for the hepatitis C virus. Hepatology, v. 46, n. 1, p. 37-47, 2007.
BEDOSSA, Pierre; DARGÈRE, Delphine; PARADIS, Valerie. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology, v. 38, n. 6, p. 1449-1457, 2003.
BENHAMOU, Yves et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology, v. 30, n. 4, p. 1054-1058, 1999.
BESTE, Lauren A. et al. Predictors of early treatment discontinuation among patients with genotype 1 hepatitis C and implications for viral eradication. Clinical Gastroenterology and
Hepatology, v. 8, n. 11, p. 972-978, 2010.
BIANCHI, Giampaolo et al. Prognostic significance of diabetes in patients with cirrhosis. Hepatology, v. 20, n. 1, p. 119-125, 1994.
BLATT, Carine Raquel et al. An estimate of the cost of hepatitis C treatment for the Brazilian health system. Value in Health Regional Issues, v. 1, n. 2, p. 129-135, 2012. BOESECKE, Christoph; WEDEMEYER, Heiner; ROCKSTROH, Jürgen Kurt. Diagnosis and treatment of acute hepatitis C virus infection. Infectious disease clinics of North
America, v. 26, n. 4, p. 995-1010, 2012.
BOHTE, Anneloes E. et al. MR elastography of the liver: defining thresholds for detecting viscoelastic changes. Radiology, v. 269, n. 3, p. 768-776, 2013.
BONACINI, M. et al. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. The American journal of gastroenterology, v. 92, n. 8, p. 1302-1304, 1997.
BONIS, Peter AL et al. A predictive model for the development of hepatocellular carcinoma, liver failure, or liver transplantation for patients presenting to clinic with chronic hepatitis C.
The American journal of gastroenterology, v. 94, n. 6, p. 1605-1612, 1999.
BONKOVSKY, Herbert L. et al. Hepatic Iron Concentration: Noninvasive Estimation by Means of MR Imaging Techniques 1. Radiology, v. 212, n. 1, p. 227-234, 1999.
BRAVO, Arturo A.; SHETH, Sunil G.; CHOPRA, Sanjiv. Liver biopsy. New England
Journal of Medicine, v. 344, n. 7, p. 495-500, 2001.
BRUIX, Jordi et al. Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C. Gastroenterology, v. 140, n. 7, p. 1990-1999, 2011.
CACCIOLA, Irene et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. New England Journal of Medicine, v. 341, n. 1, p. 22-26, 1999.
CALDWELL, Stephen H. et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology, v. 44, n. 4, p. 1039-1046, 2006.
CAMMA, Calogero et al. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. Hepatology, v. 43, n. 1, p. 64-71, 2006.
CARONIA, Simona et al. Further evidence for an association between non–insulin‐
dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology, v. 30, n. 4, p. 1059-1063, 1999.
CASTÉRA, Laurent et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology, v. 128, n. 2, p. 343-350, 2005.
CDC, Http://www.cdc.gov/hepatitis/Statistics/index.htm, 2011.
CHIN, Rachel L. Postexposure prophylaxis for HIV. Emergency medicine clinics of North
America, v. 28, n. 2, p. 421-429, 2010
CHOPRA, S. Epidemiology and transmission of Hepatitis C virus infection. UptoDate, v. 8, 2004.
CHOPRA, S. Epidemiology and transmission of Hepatitis C virus infection. UptoDate, v. 19, 2011.
CHOPRA S, Di Bisceglie MD, et al. Epidemiology and transmission of hepatitis c virus infection, Uptodate, v. 19, 2011.
CHOPRA, Sanjiv et al. Treatment regimens for chronic hepatitis C virus genotype 1. 2012 CHOU, Roger; WASSON, N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Annals of internal medicine, v. 158, n. 11, p. 807-820, 2013.
CHU, Chi‐Jen; LEE, Shou‐Dong. Hepatitis B virus/hepatitis C virus coinfection:
epidemiology, clinical features, viral interactions and treatment. Journal of
CONN, HO. Atterbury CE. Cirrhosis in SCHIFF, Leon et al. (Ed.). Diseases of the Liver. Philadelphia: Lippincott, 1993.
COSTA, Luciano Bello et al. Effect of host-related factors on the intensity of liver fibrosis in patients with chronic hepatitis C virus infection. Brazilian Journal of Infectious Diseases, v. 6, n. 5, p. 219-224, 2002.
CROQUET, Vincent et al. Prothrombin index is an indirect marker of severe liver fibrosis.
European journal of gastroenterology & hepatology, v. 14, n. 10, p. 1133-1141, 2002.
CROSWELL, Jennifer M.; RANSOHOFF, David F.; KRAMER, Barnett S. Principles of cancer screening: lessons from history and study design issues. In: Seminars in oncology. WB Saunders, 2010. p. 202-215.
CUSTRO, N. et al. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis.
Diabetes & metabolism, v. 27, n. 4 Pt 1, p. 476-481, 2001.
D'AMICO, Gennaro; GARCIA-TSAO, Guadalupe; PAGLIARO, Luigi. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. Journal of
hepatology, v. 44, n. 1, p. 217-231, 2006.
DANTA, Mark et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. Aids, v. 21, n. 8, p. 983-991, 2007. DE LOPE, Carlos Rodríguez et al. Management of HCC. Journal of hepatology, v. 56, p. S75-S87, 2012.
DELGADO‐BORREGO, Aymin et al. Prospective study of liver transplant recipients with
HCV infection: evidence for a causal relationship between HCV and insulin resistance. Liver
transplantation, v. 14, n. 2, p. 193-201, 2008.
DENNISTON, Maxine M. et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Annals of internal
medicine, v. 160, n. 5, p. 293-300, 2014.
DI BISCEGLIE, A.M, Predictors of a sustained virologic responce following treatment peginterferon and ribavirin for chronic hepatitis C virus infection. UPTODATE, 2012.
DI BISCEGLIE, Adrian M. et al. Excess mortality in patients with advanced chronic hepatitis
C treated with long‐term peginterferon. Hepatology, v. 53, n. 4, p. 1100-1108, 2011.
DIEPERINK, Eric et al. All-cause mortality and liver-related outcomes following successful antiviral treatment for chronic hepatitis C. Digestive diseases and sciences, v. 59, n. 4, p. 872-880, 2014.
DOUGLAS, Mark W.; GEORGE, Jacob. Molecular mechanisms of insulin resistance in chronic hepatitis C. World journal of gastroenterology: WJG, v. 15, n. 35, p. 4356, 2009. DURAND, François; VALLA, Dominique. Assessment of the prognosis of cirrhosis: Child– Pugh versus MELD. Journal of hepatology, v. 42, n. 1, p. S100-S107, 2005.
DE LOPE, Carlos Rodríguez et al. Management of HCC. Journal of hepatology, v. 56, p.
S75-S87, 2012.
ELKRIEF, Laure et al. Diabetes mellitus is an independent prognostic factor for major liver‐
related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology, v. 60, n. 3, p. 823-831, 2014.
EL-MEZAYEN, Hatem A.; DARWISH, Hossam. Development of a novel score for early detection of hepatocellular carcinoma among high-risk hepatitis C virus patients. Tumor
Biology, v. 35, n. 7, p. 6501-6509, 2014.
EVERHART, James E. et al. Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology, v. 137, n. 2, p. 549- 557, 2009.
EVERHART, James E.; WRIGHT, Elizabeth C. Association of ‐glutamyl transferase (GGT)
activity with treatment and clinical outcomes in chronic hepatitis C (HCV). Hepatology, v. 57, n. 5, p. 1725-1733, 2013.
FABRIZI, Fabrizio et al. Hepatitis C virus infection and post-transplant diabetes mellitus among renal transplant patients: a meta-analysis. The International journal of artificial
FATTOVICH, GIOVANNA et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology, v. 112, n. 2, p. 463-472, 1997.
FERREIRA, Raquel et al. Hepatite C Crônica, uma doença metabólica. Revista de Medicina
e Saúde de Brasília, v. 1, n. 2, 2012.
FEUCHT, Heinz‐hubert et al. Greater Amount of HCV‐RNA in Tears Compared to Blood.
Microbiology and immunology, v. 38, n. 2, p. 157-158, 1994.
FINN, J. P. et al. Imaging of the portal venous system in patients with cirrhosis: MR
angiography vs duplex Doppler sonography. AJR. American journal of roentgenology, v.
161, n. 5, p. 989-994, 1993.
FISSELL, Rachel B. et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney international, v. 65, n. 6, p. 2335-2342, 2004.
FONTANA, Robert J. et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology, v. 47, n. 3, p. 789-798, 2008.
FORNARI, Adriana. Avaliação de medidas de resistência e secreção de insulina em pacientes HCV positivos. 2008
FORNER, A; Llovet, J M. et al. Hepatocellular carcinoma seminar, published online www.thelancet.com, February 20, 2012.
FORNS, Xavier et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology, v. 36, n. 4, p. 986-992, 2002.
FOSTER, G. R. et al. Management of chronic hepatitis C: clinical audit of biopsy based management algorithm. Bmj, v. 315, n. 7106, p. 453-458, 1997.
FREEDMAN, Neal D. et al. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology, v. 50, n. 5, p. 1360-1369, 2009.
FREEMAN, A. J. et al. Predicting progression to cirrhosis in chronic hepatitis C virus infection. Journal of viral hepatitis, v. 10, n. 4, p. 285-293, 2003.
FUJITA, Naoki et al. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. Free Radical Biology and medicine, v. 42, n. 3, p. 353-362, 2007.
GHANY, Marc G. et al. Diagnosis, management, and treatment of hepatitis C: an update.
Hepatology, v. 49, n. 4, p. 1335-1374, 2009.
GHANY, Marc G. et al. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology, v. 138, n. 1, p. 136-146, 2010.
GIORDANINO, Chiara et al. Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study. Digestive and Liver Disease, v. 44, n. 5, p. 406-412, 2012.
GOLDBERG E, Chopra S, Cirrhosis in adults: Etiologies, clinical manifestations and diagnosis. UPTODATE, 18.0, 2015.
GOLDBERG E, Chopra S, Runyon B A. Travis A C. Cirrhosis in adults: Overview of complications, general management, and prognosis. UPTODATE 17.0. 2014.
GRECA, Laura Fachin et al. Clinical features of patients with type 2 diabetes mellitus and hepatitis C infection. Brazilian Journal of Medical and Biological Research, v. 45, n. 3, p. 284-290, 2012.
ITO, K. et al. Viral-induced cirrhosis: grading of severity using MR imaging. AJR. American journal of roentgenology, v. 173, n. 3, p. 591-596, 1999.
HATZAKIS, Angelos et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. Journal of Viral Hepatitis, v. 18, n. s1, p. 1-16, 2011.
HÉZODE, Christophe et al. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology, v. 42, n. 1, p. 63-71, 2005.
HUANG, Yi‐Wen et al. Increased risk of cirrhosis and its decompensation in chronic
hepatitis C patients with new‐onset diabetes: A nationwide cohort study. Hepatology, v. 60,
n. 3, p. 807-814, 2014.
HUNG, Chao-Hung et al. Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection. World journal of gastroenterology: WJG, v. 16, n. 18, p. 2265, 2010.
HUWART, Laurent et al. Liver Fibrosis: Noninvasive Assessment with MR Elastography versus Aspartate Aminotransferase–to-Platelet Ratio Index 1. Radiology, v. 245, n. 2, p. 458- 466, 2007.
HWANG, E. W. et al. Implications of rapid virological response in hepatitis C therapy in the US veteran population. Alimentary pharmacology & therapeutics, v. 35, n. 1, p. 105-115, 2012.
HWANG SJ, Chen LK. Chronic Hepatitis C and Diabetes Mellitus. J Chin Med Assoc. 69(4):143-5. 2006.
IMBERT-BISMUT, Françoise et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. The Lancet, v. 357, n. 9262, p. 1069-1075, 2001.
ISLAM, Sara et al. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers. Scandinavian journal of gastroenterology, v. 40, n. 7, p. 867-872, 2005.
JAFFER, O. S. et al. Acoustic radiation force impulse quantification: repeatability of measurements in selected liver segments and influence of age, body mass index and liver capsule-to-box distance. The British journal of radiology, 2014.
JOHN-BAPTISTE, Ava et al. The natural history of hepatitis C infection acquired through injection drug use: meta-analysis and meta-regression. Journal of hepatology, v. 53, n. 2, p. 245-251, 2010.
KABBAJ, N. et al. Hépatite virale C et diabète: influence du diabète sur l’évolution de l’hépatopathie. In: Annales d'endocrinologie. Elsevier Masson, 2006. p. 233-237.
KAMATH, Patrick S.; KIM, W. The model for end‐stage liver disease (MELD).
Hepatology, v. 45, n. 3, p. 797-805, 2007.
KANEDA, Kazuhisa et al. The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus‐related hepatocellular carcinoma.
Journal of surgical oncology, v. 105, n. 6, p. 606-611, 2012.
KAROUI, S. et al. [Predictive factors of fibrosis for chronic viral hepatitis C]. La Tunisie
medicale, v. 85, n. 6, p. 454-460, 2007.
KHAN, Mahbub H. et al. Which patients with hepatitis C develop liver complications?.
Hepatology, v. 31, n. 2, p. 513-520, 2000.
KINIRONS, Stacy A.; DO, Sandy. The Acute Care Physical Therapy HIV/AIDS Patient Population A Descriptive Study. Journal of the International Association of Providers of
AIDS Care (JIAPAC), p. 2325957413476552, 2013.
KNOBLER, Hilla et al. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. In: Mayo Clinic Proceedings. Elsevier, 2000. p. 355-359.
KOBAYASHI, Masanori et al. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology, v. 23, n. 4, p. 695- 699, 1996.
KODA, Masahiko et al. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology, v. 45, n. 2, p. 297-306, 2007.
KOH, W. P. et al. Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. British journal of cancer, v. 108, n. 5, p. 1182-1188, 2013.
KONDO, Reiichiro et al. Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C. Journal of
KRAUS, Michael Rupert et al. Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition.
Digestive diseases and sciences, v. 46, n. 10, p. 2060-2065, 2001.
KRZESKI, Piotr et al. Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis? Hepatology, v. 30, n. 4, p. 865-869, 1999.
LACKNER, Carolin et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology, v. 41, n. 6, p. 1376-1382, 2005. LAMBRECHT, Richard W. et al. Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology, v. 140, n. 5, p. 1490-1500. e3, 2011.
LARSON, A. M.; CARITHERS, R. L. Hepatitis C in clinical practice. Journal of internal
medicine, v. 249, n. 2, p. 111-120, 2001.
LAWSON, Adam et al. The natural history of hepatitis C with severe hepatic fibrosis.
Journal of hepatology, v. 47, n. 1, p. 37-45, 2007.
LAUER, Georg M.; WALKER, Bruce D. Hepatitis C virus infection. New England Journal
of Medicine, v. 345, n. 1, p. 41-52, 2001.
LECUBE, Albert et al. Proinflammatory Cytokines, Insulin Resistance, and Insulin Secretion in Chronic Hepatitis C patients A case-control study. Diabetes Care, v. 29, n. 5, p. 1096- 1101, 2006.
LIANG, T. Jake et al. Pathogenesis, natural history, treatment, and prevention of hepatitis C.
Annals of internal medicine, v. 132, n. 4, p. 296-305, 2000.
LIANG, T. Jake; GHANY, Marc G. Current and future therapies for hepatitis C virus infection. New England Journal of Medicine, v. 368, n. 20, p. 1907-1917, 2013
LIMA, J. M. C; Fernandes, S. G. et al. Avaliação do escore FIB 4 no diagnóstico de fibrose
hepática em pacientes com hepatite crônica pelo vírus C. Gastroenterol Endosc. Digest, 26, sup 1. S 32-. 2007.
LISMAN, Ton; LEEBEEK, Frank WG; DE GROOT, Philip G. Haemostatic abnormalities in patients with liver disease. Journal of hepatology, v. 37, n. 2, p. 280-287, 2002.
LIVINGSTON, Stephen E. et al. Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C. Canadian
Journal of Gastroenterology, v. 24, n. 7, p. 445, 2010.
LOK, Anna SF et al. Predicting cirrhosis in patients with hepatitis C based on standard
laboratory tests: results of the HALT‐C cohort. Hepatology, v. 42, n. 2, p. 282-292, 2005.
LOWRY, Damien J. et al. Hepatitis C management: the challenge of dropout associated with male sex and injection drug use. European journal of gastroenterology & hepatology, v. 23, n. 1, p. 32-40, 2011.
LU, Sheng‐Nan et al. Thrombocytopenia as a surrogate for cirrhosis and a marker for the
identification of patients at high‐risk for hepatocellular carcinoma. Cancer, v. 107, n. 9, p.
2212-2222, 2006.
MACDONALD, Douglas C. et al. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. World journal of gastroenterology: WJG, v. 14, n. 11, p. 1657, 2008.
MCPHERSON, Stuart et al. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut, v. 59, n. 9, p. 1265-1269, 2010.
MAKRIS, M. et al. The natural history of chronic hepatitis C in haemophiliacs. British
journal of haematology, v. 94, n. 4, p. 746-752, 1996.
MARABITA, Francesco et al. Genetic variation in the interleukin‐28B gene is not associated
with fibrosis progression in patients with chronic hepatitis C and known date of infection.
Hepatology, v. 54, n. 4, p. 1127-1134, 2011.
MARCELLIN, Patrick; ASSELAH, Tarik; BOYER, Nathalie. Fibrosis and disease progression in hepatitis C. Hepatology, v. 36, n. 5B, p. s47-s56, 2002.
MARTINS, Tatiana; NARCISO-SCHIAVON, Janaína Luz; DE LUCCA SCHIAVON, Leonardo. Epidemiologia da infecção pelo vírus da hepatite C. Revista da Associação
Médica Brasileira, v. 57, n. 1, p. 107-112, 2011.
MASON, Andrew L. et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology, v. 29, n. 2, p. 328-333, 1999.
MASOOD, Muhammed Adnan; ZAFAR, Waleed; YUSUF, Muhammed Aasim. Is diabetes mellitus a poor prognostic factor for hepatocellular carcinoma? Journal of gastrointestinal
cancer, v. 45, n. 4, p. 448-451, 2014.
MEHTA, Shruti H. et al. Hepatitis C virus infection and incident type 2 diabetes.
Hepatology, v. 38, n. 1, p. 50-56, 2003.
MELO, Luciana Oliveira de Rezende; MONTEIRO, Denise Leite Maia; RODRIGUES, Nádia Cristina Pinheiro. Factors associated with treatment interruption for hepatitis C.
Revista da Associação Médica Brasileira, v. 60, n. 1, p. 29-34, 2014.
MERICAN, I. et al. Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. QJM, v. 86, n. 2, p. 119-125, 1993.
Ministério da Saúde. HIV/Aids, hepatites e outras DST. Cadernos de atenção básica, n. 18. Brasil: Editora MS: 164-165, 2006.
MIR, Heshaam M. et al. African Americans are less likely to have clearance of hepatitis C virus infection: the findings from recent US population data. Journal of clinical
gastroenterology, v. 46, n. 8, p. e62-e65, 2012.
MMWR Recomm Rep. 50(RR-11):1Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for PostexposureProphylaxis., 50, RR 11.2001
MOHD HANAFIAH, Khayriyyah et al. Global epidemiology of hepatitis C virus infection:
New estimates of age‐specific antibody to HCV seroprevalence. Hepatology, v. 57, n. 4, p.
MONTO, Alexander et al. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology, v. 36, n. 3, p. 729-736, 2002.
MORGAN, Rebecca L. et al. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Annals of internal
medicine, v. 158, n. 5_Part_1, p. 329-337, 2013.
MORGAN, Timothy R. et al. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology, v. 52, n. 3, p. 833-844, 2010.
MOURAD, Abbas et al. Hepatocellular carcinoma screening in patients with compensated
hepatitis C virus (HCV) ‐related cirrhosis aware of their HCV status improves survival: A
modeling approach. Hepatology, v. 59, n. 4, p. 1471-1481, 2014.
MUKHTAR, Nizar A. et al. Insulin sensitivity and variability in hepatitis C virus infection using direct measurement. Digestive diseases and sciences, v. 58, n. 4, p. 1141-1148, 2013. MYERS, Robert P. et al. Biochemical markers of fibrosis in patients with chronic hepatitis C:
a comparison with prothrombin time, platelet count, and age–platelet index. Digestive
diseases and sciences, v. 48, n. 1, p. 146-153, 2003.
NAING, Cho et al. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. World journal of gastroenterology: WJG, v. 18, n. 14, p. 1642, 2012.
NIEDERAU, Claus et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology, v. 28, n. 6, p. 1687-1695, 1998.
NIERHOFF, Julia et al. The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis. European radiology, v. 23, n. 11, p. 3040-3053, 2013.
NKONTCHOU, Gisèle et al. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. The Journal of Clinical Endocrinology &
OSHITA, Masahide et al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology, v. 20, n. 5, p. 1115-1120, 1994.
OSTAPOWICZ, George et al. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology, v. 27, n. 6, p. 1730-1735, 1998.
PAPATHEODORIDIS, G. V. et al. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis. Journal of viral
hepatitis, v. 13, n. 5, p. 303-310, 2006.
PEMBREY, Lucy et al. The management of HCV infected pregnant women and their children European paediatric HCV network. Journal of hepatology, v. 43, n. 3, p. 515-525, 2005.
PERRAULT, Jean et al. Liver biopsy: complications in 1000 inpatients and outpatients.
Gastroenterology, v. 74, n. 1, p. 103-106, 1978.
PERZ, Joseph F. et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of hepatology, v. 45, n. 4, p. 529- 538, 2006.
PESSIONE, Fabienne et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology, v. 27, n. 6, p. 1717-1722, 1998. PETTA, Salvatore et al. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. The American journal of gastroenterology, v. 103, n. 5, p. 1136-1144, 2008.
PICCININO, F. et al. Complications following percutaneous liver biopsy: a multicentre retrospective study on 68 276 biopsies. Journal of hepatology, v. 2, n. 2, p. 165-173, 1986. POYNARD, Thierry et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The Lancet, v. 349, n. 9055, p. 825-832, 1997.
POYNARD, Thierry et al. Natural history of liver fibrosis progression in patients with